This inventor holds 8 USPTO granted patents. Top assignees: Smithkline Beecham Corporation, Glaxosmithkline LLC. Active years: 1997-2011.
Company Filing History:
11 out of 2,198 
1 out of 358 
Years Active: 1997-2011
Title: **The Innovative Journey of Richard M. Cook**
Introduction
Richard M. Cook is a notable inventor based in Chester Springs, Pennsylvania, who has made significant contributions to the field of medical science. With a total of eight patents to his name, Cook has focused his research on addressing IL-5 mediated disorders through innovative pharmaceutical solutions.
Latest Patents
Among his latest patents, Cook has developed recombinant IL-5 antagonists, which are instrumental in treating various IL-5 mediated disorders. These include chimeric and humanized IL-5 monoclonal antibodies derived from high-affinity neutralizing monoclonal antibodies. His work provides pharmaceutical compositions containing these antagonists, along with methods for treatment and diagnostics, enhancing the therapeutic landscape for patients affected by these disorders.
Career Highlights
Throughout his career, Richard M. Cook has worked with prominent companies in the pharmaceutical industry, including SmithKline Beecham Corporation and GlaxoSmithKline LLC. His extensive experience in these organizations has undoubtedly influenced his innovative approach to drug development and patent creation.
Collaborations
Cook has collaborated with esteemed colleagues such as Edward Robert Appelbaum and Robert S. Ames, further enriching his research efforts and expanding the scope of his inventions. These partnerships have facilitated the advancement of his projects in the field of biotechnology.
Conclusion
With eight patents to his credit, Richard M. Cook continues to push the boundaries of innovation in medical treatments. His groundbreaking work in recombinant IL-5 antagonists showcases his dedication to finding solutions for complex health challenges, ensuring a lasting impact on the pharmaceutical landscape.